|
|
Barbara Davis Center for Childhood Diabetes
Research Funding
(listed alphabetically by Principal Investigator or by Section faculty member involved)
2005
Glucose Sensors in Children with Type 1 Diabetes
Principal Investigator: H. Peter Chase, MD
Source: National Institutes of Health - 1 U10 HD041919
Amount: $352,000/yr
Term: 2001-2006
Efficacy and Safety of Insulin Glulisine Compared with Insulin Lispro in Children and Adolescents with Type 1 Diabetes Mellitus
Principal Investigator: H. Peter Chase, MD
Source: Aventis Pharmaceuticals Inc.
Amount: $48,000
Term: 2004-2007
External Continuous Subcutaneous Infusion of Insulin Aspart (Novolog) vs. Insulin Lispro (Humalog)
Principal Investigator: H. Peter Chase, MD
Source: Novo Nordisk Pharmaceuticals, Inc.
Amount: $43,991
Term: 2004-2006
An Accuracy Evaluation of the Medtronic Diabetes Guardian RT Glucose Monitoring System in Pediatric Subjects with Type 1 Diabetes
Principal Investigator: H. Peter Chase, MD
Source: Medtronic Diabetes
Amount: $34,100
Term: 2005-2006
Ancillary Study to Evaluate the Effect of Insulin Pumps with Direct Integration of SMBG Hb
Principal Investigator: H. Peter Chase, MD
Source: Smiths Medical MD, Inc.
Amount: $55,125
Term: 2004-2007
Active Tolerosomes, a Novel Therapy for Type 1 Diabetes
Principal Investigator: Howard Davidson, BSc, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - R21 DK066043
Amount: $100,000/yr
Term: 2005-2007
Antibodies to Recombinant Autoantigens: Prediction/Immunogenetics
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health, National Institute of Allergy and Infectious Diseases - 2 R01 AI39213-06
Amount: $202,500
Term: 2001-2005
Autoimmunity Prevention Center
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health, National Institute of Allergy and Infectious Diseases
Amount: $5,012,089
Term: 2001-2005
Core Autoantibody Determination Laboratory for Immune Tolerance Network
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health, National Institute of Allergy and Infectious Diseases - N01-AI-95380
Amount: $151,000/yr
Term: 1999-2006
Diabetes and Endocrinology Research Center
Principal Investigator: John Hutton, PhD
Co-Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health - P30 DK57516
Amount: $1,249,431
Term: 2005-2010
In Vivo NOD Evaluation of a "Pathogenic" Insulin Peptide
Principal Investigator: George S. Eisenbarth, MD, PhD
Co-Investigator: Dirk Homann, MD, PhD
Source: National Institutes of Health - R01 DK55969
Amount: $189,241/yr
Term: 1998-2006
Mentor-Based Fellowship
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: American Diabetes Association
Amount: $45,000/yr
Term: 1998-2005
Modeling and Detecting Pathogens of Islet Autoimmunity
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - 1 R01 DK62718
Amount: $100,000/yr
Term: 2002-2006
Multiple Autoantigens/Multiple Epitopes of Pre-Type I Diabetes Mellitus
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - 2 R01 DK32083-20A2
Amount: $166,250/yr
Term: 2001-2005
Type 1 Diabetes TrialNet, HLA (Autoantibody Laboratory Subcontract)
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - U01-DK61055-01
Amount: $363,820
Term: 2002-2008
Immunogenetics of Type 1 Diabetes in a Bedouin Arab Family
Principal Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health - RO1 DK57538
Amount: $275,000/yr
Term: 2000-2005
Islet-Cell Autoimmunity: Are Dizgotic Twins the Same as Siblings?
Principal Investigator: Pamela R. Fain, PhD
Source: American Diabetes Association - 1-04-RA-23
Term: 2004-2006
Type 1 Genetics Consortium (Subcontract)
Principal Investigator: Rosanna V. Fiallo-Scharer, MD
Source: Benaroya Research Institute at Virginia Mason
Amount: $183,669
Term: 2003-2006
Aventis HOE 901/4016
Principal Investigator: Satish K. Garg, MD
Co-Investigator: William E. Jackson, MD
Source: Quintiles/Aventis
Amount: $34,000
Term: 2001-2006
Lantus plus Apidra MDI vs. Apidra MDI vs. Premix Insulin Treatment in Subjects with Diabetes Mellitus
Principal Investigator: Satish K. Garg, MD
Source: Quintiles/Aventis
Amount: $61,800
Term: 2004-2008
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus
Principal Investigator: Satish K. Garg, MD
Source: Eli Lilly & Company
Amount: $1,294,260
Term: 2005-2009
Glycemic Control and Prevention of Hypoglycemia in Intensively Treated Subjects with Type 1 Diabetes Using Accu-Check Advisor Insulin Guidance Software
Principal Investigator: Satish K. Garg, MD
Source: Roche Diagnostics Corporation
Amount: $573,300
Term: 2005-2010
Safety and Efficacy of the DexCom G2 Glucose Sensor in Patients with Diabetes Mellitus
Principal Investigator: Satish K. Garg, MD
Source: DexCom, Inc.
Amount: $400,000
Term: 2004-2008
Markers and Mechanisms for Pre-Eclampsia in Women with Type 1 Diabetes
Principal Investigator: Satish K. Garg, MD
Source: NovoNordisk
Amount: $15,000
Term: 2005-2007
No Invasive Glucose Monitor Testing Using the Critical Care Monitor in Subjects with Type 1 Diabetes
Principal Investigator: Satish K. Garg, MD
Source: Nostix
Amount: $44,600
Term: 2005-2007
Protocol for User Evaluation of the Performance of the AgaMatrix KeyNote Blood Glucose
Principal Investigator: Satish K. Garg, MD
Source: AgaMatrix
Amount: $45,000
Term: 2005-2007
Immunobiology of Pancreatic Islet Xenografting
Principal Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - 5 R01 DK045773
Amount: $198,503/yr
Term: 1993-2006
Islet Cell Resources (ICR) Facility at the University of Colorado Denver
Principal Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - U42 RR016599
Amount: $663,156/yr
Term: 2001-2006
Reversal of Diabetes by Islet Transplantation
Principal Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - R01 DK33470
Amount: $284,130
Term: 1984-2007
T-Cell Mediated Injury to Islet Allografts
Principal Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - R01 DK55333
Amount: $143,568/yr
Term: 1998-2005
Use of Hematopoietic Stem Cells for the Regulation of Autoimmune Diabetes
Principal Investigator: Ronald G. Gill, PhD
Source: Juvenile Diabetes Research Foundation, 1-2003-737
Amount: $144,656/yr
Term: 2005-2006
Use of Hematopoietic Stem Cells for the Regulation of Autoimmune Diabetes
Principal Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - R21 AI060349
Amount: $150,000/yr
Term: 2003-2006
Diabetes Prevention Trial-1 (Clinical Center Subcontract)
Principal Investigator: Peter A. Gottlieb, MD
Source: National Institutes of Health, Juvenile Diabetes Foundation, American Diabetes Association - 5 U01 DK60782
Amount: $377,395/yr
Term: 2001-2008
Treatment with hOKT3g1 (Ala-Ala) in T1DM
Principal Investigator: Peter A. Gottlieb, MD
Source: ITN/Immune Tolerance Network
Amount: $116,094
Term: 2005-2007
North American Cytokine ELISpot Laboratory
Principal Investigator: Peter A. Gottlieb, MD
Source: National Institutes of Health
Amount: $200,000/yr
Term: 2005-2007
Role of Regulatory CD4+ and CD25+ T-Cells in Diabetes
Principal Investigator: Peter A. Gottlieb, MD
Source: Brigham and Women's Hospital
Amount: $29,000/yr
Term: 2005-2007
Tolerability and Safety of Multiple-Dose Regimen of TRX4 Anti-CD3 Monoclonal Antibody Type 1 Diabetes Mellitus
Principal Investigator: Peter A. Gottlieb, MD
Source: TolerRx
Amount: $24,572
Term: 2005-2007
Proteomics Analysis of T-Cell Autoantigens in T1D2
Principal Investigator: Kathryn Haskins, PhD
Co-Investigators: John Hutton, PhD, and Howard Davidson, BSc, PhD
Source: National Institutes of Health - R21 AI065355
Amount: $200,000/yr
Term: 2004-2006
Denver Autoimmunity Center of Excellence
Project II: Complement in the Immunopathogenesis of Autoimmune Diabetes
Principal Investigator: V. Michael Holers, MD
Co-Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health, National Institute of Allergy and Infectious Diseases - U19 AI46374
Amount: $150,000/yr
Term: 2003-2008
Denver Autoimmunity Center of Excellence
Principal Investigator: V. Michael Holers, MD
Basic Project III: Genetic Analysis of Autoimmune Polyendocrine Syndrome-II
Principal Investigator: Richard A. Spritz, MD
Co-Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health, National Institute of Allergy and Infectious Diseases - U19 AI46374
Amount: $150,000/yr
Term: 2003-2008
Maturation of Established Antiviral CD8 T-Cell Memory
Principal Investigator: Dirk Homann, MD, PhD
Source: National Institutes of Health - R21 AG026518
Amount: $125,000/yr
Term: 2005-2007
Cloning of Molecular Targets of CMI in Type 1 Diabetes
Principal Investigator: John Hutton, PhD
Co-Investigator: Howard Davidson, BSc, PhD
Source: National Institutes of Health - R01 DK052068
Amount: $225,000/yr
Term: 2005-2010
Development and Regeneration of the Endocrine Pancreas
Principal Investigator: John Hutton, PhD
Co-Investigator: Jan C. Jensen, MSc, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - U19 DK61248
Amount: $957,037/yr
Term: 2001-2005
Diabetes and Endocrinology Research Center
Principal Investigator: John Hutton, PhD
Co-Investigators: Ronald G. Gill, PhD, Howard Davidson, BSc, PhD, and Dirk Homann, MD, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - P30 DK57516
Amount: $972,233/yr
Term: 2000-2010
Islet G6Pase-Related Protein: A Novel -cell Specific Target for T-Cell Mediated Autoimmunity in Type 1 Diabetes
Principal Investigator: John Hutton, PhD
Co-Investigator: Howard Davidson, BSc, PhD
Source: American Diabetes Association - 1-04-RA-44
Amount: $86,957/yr
Term: 2004-2006
Mentor-Based Postdoctoral Fellowship Program
Principal Investigator: John Hutton, PhD
Source: American Diabetes Association - 7-04-MN-19
Amount: $45,000/yr
Term: 2000-2008
Tryptophan Metabolism in Type 1 Diabetes
Principal Investigator: John Hutton, PhD
Co-Investigator: Howard Davidson, BSc, PhD
Source: Juvenile Diabetes Research Foundation - 1-2005-145
Amount: $150,000/yr
Term: 2005-2008
Open-Label Treatment for Patients Completing Study B7A-MC-MBMC
Principal Investigator: William Jackson, MD
Source: Eli Lilly and Company
Amount: $39,834
Term: 2006-2009
Molecular Mechanism of FGF10 Signaling in Pancreatic Development
Principal Investigator: Jan Jensen, MSc, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - R01 DK070636-01A1
Amount: $225,000/yr
Term: 2005-2010
Morphogenetic Control of ß-cell Specification
Principal Investigator: Jan Jensen, MSc, PhD
Source: American Diabetes Association - ADA 7-01-CD-11
Amount: $193,599/yr
Term: 2001-2006
Studies Investigating the Role of Mybl2 in B-Cells
Principal Investigator: Jan Jensen, MSc, PhD
Source: Juvenile Diabetes Research Foundation - JDRF 5-2005-914
Amount: $100,000/yr
Term: 2005-2006
Diabetes Research for Pediatric Endocrinologists (K12) and Fellows Training Grant (T32)
Principal Investigator: Georgeanna J. Klingensmith, MD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - 5 K12 DK063722-03 and 5 T32 DK063687-03
Amount: $288,963/yr (K12); $174,996/yr (T32)
Term: 2002-2007
Cell Cycle Inhibition in Systemic Autoimmunity
Principal Investigator: Dwight Kono, MD
Co-Investigator: Dirk Homman, MD, PhD
Source: National Institutes of Health - R01AI059777
Amount: $1,000,000
Term: 2005-2010
Molecular Epidemiology of Dilated Cardiomyopathy
Principal Investigator: Luisa Mestroni, MD
Co-Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - RO1 HL69071
Amount: $494,290/yr
Term: 2001-2005
Viability Assay for Human Islet Transplantation
Principal Investigator: Mark Nicolls, MD
Co-Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health - R21 DK70203
Amount: $250,000/yr
Term: 2004-2006
The Mechanism of CD40 T-Cell Dependent Acute Cardiac Allograft Rejection
Principal Investigator: Biagio A. Pietra, MD
Co-Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health - R01 HL67976
Amount: $225,000/yr
Term: 2001-2006
Coronary Artery Calcification in Type 1 Diabetes
Principal Investigator: Marian J. Rewers, MD, PhD, MPH
Source: National Institutes of Health, National Heart, Lung, and Blood Institute - R01 HL61753
Amount: $437,000/yr
Term: 1999-2008
Determinants of Accelerated CVD in Type 1 Diabetes
Principal Investigator: Marian J. Rewers, MD, PhD, MPH
Source: National Institutes of Health, National Heart, Lung, and Blood Institute - RO1 HL079611
Amount: $1,536,537
Term: 2004-2008
Diabetes Autoimmunity Study in the Young (DAISY)
Principal Investigator: Marion J. Rewers, MD, PhD, MPH
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - RO1 DK32493
Amount: $3,111,271
Term: 1993-2006
Environmental Causes of Type 1 Diabetes (TEDDY)
Principal Investigator: Marian J. Rewers, MD, PhD, MPH
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - U01 DK63821
Amount: $3,253,203
Term: 2002-2007
Genetic and Environmental Causes of Celiac Disease
Principal Investigator: Marian J. Rewers, MD, PhD, MPH
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - R01 DK50979
Amount: $1,610,342
Term: 1995-2006
Natural History of Pre-Diabetic Autoimmunity
Principal Investigator: Marian J. Rewers, MD, PhD, MPH
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases - R01 DK32493
Amount: $4,052,324
Term: 1997-2006
Modifier Genes in Autosomal Dominant Polycystic Kidney Disease
Principal Investigator: Robert Schrier, MD
Co-Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - PO1 DK034039, Project 2
Amount: $150,000/yr
Term: 2001-2006
Microalbuminuria in Diabetes in Children
Principal Investigator: Robert H. Slover II, MD
Source: Boehringer Ingelheim Pharmaceuticals
Amount: $67,500
Term: 2005-2006
Mapping of Vitiligo Susceptibility Genes
Principal Investigator: Richard Spritz, MD
Co-Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health - 5 R01 AROH5584-06
Amount: $547,668
Term: 2004-2009
2003-2004
Diabetes Prevention Trial-1 (Clinical Center Subcontract)
Principal Investigator: H. Peter Chase, MD
Source: National Institutes of Health, Juvenile Diabetes Foundation, American Diabetes Association - 5 U01 DK60782
Amount: $377,395/yr
Term: 2001-2008
Glucose Sensors in Children with Type 1 Diabetes
Principal Investigator: H. Peter Chase, MD
Source: National Institutes of Health - 1 U10 HD041919
Amount: $352,000/yr
Term: 2001-2006
Autoimmunity Prevention Center
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health, National Institute of Allergy and Infectious Diseases
Amount: $5,012,089
Term: 2001-2005
Type 1 Diabetes TrialNet, HLA (Autoantibody Laboratory Subcontract)
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - U01-DK61055-01
Amount: $363,820
Term: 2002-2008
Antibodies to Recombinant Autoantigens: Prediction/Immunogenetics
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health, National Institute of Allergy and Infectious Diseases - 2 R01 AI39213-06
Amount: $202,500
Term: 2001-2005
In Vivo NOD Evaluation of a "Pathogenic" Insulin Peptide
Principal Investigator: George S. Eisenbarth, MD, PhD
Co-Investigator: Dale Wegmann, PhD
Source: National Institutes of Health, National Institute of Allergy and Infectious Diseases - 2 R01 DK55969
Amount: $189,241/yr
Term: 1998-2006
Multiple Autoantigens/Multiple Epitopes of Pre-Type I Diabetes Mellitus
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - 2 R01 DK32083-20A2
Amount: $166,250/yr
Term: 2001-2005
Core Autoantibody Determination Laboratory for Immune Tolerance Network
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health, National Institute of Allergy and Infectious Diseases - N01-AI-95380
Amount: $151,000/yr
Term: 1999-2006
Modeling and Detecting Pathogens of Islet Autoimmunity
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - 1 R01 DK62718
Amount: $100,000/yr
Term: 2002-2006
Mentor-Based Fellowship
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: American Diabetes Association
Amount: $45,000/yr
Term: 1998-2005
Type 1 Genetics Consortium (Subcontract)
Principal Investigator: Rosanna V. Fiallo-Scharer, MD
Source: Benaroya Research Institute at Virginia Mason
Amount: $183,669
Term: 2003-2006
Denver Autoimmunity Center of Excellence
Principal Investigator: Brian Kotzin, MD
Co-Investigators: Pamela R. Fain, PhD, and Ronald G. Gill, PhD
Source: National Institutes of Health, National Institute of Allergy and Infectious Diseases - U19AI46374
Amount: $588,707/yr
Term: 1999-2008
Islet Cell Resource Facility at UCD
Principal Investigator: Ronald G. Gill, PhD
Co-Investigator: John C. Hutton, PhD
Source: National Institutes of Health - 1 U42 RR16599
Amount: $492,558/yr
Term: 2001-2006
Reversal of Diabetes by Islet Transplantation
Principal Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health - R01 DK 33470
Amount: $184,000/yr
Term: 1998-2007
T-Cell-Mediated Injury to Islet Allografts
Principal Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health - R01 DK/AI55333
Amount: $175,000/yr
Term: 1998-2006
Use of Hematopoietic Stem Cells for the Regulation of Autoimmune Diabetes
Principal Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health - R21 AI60349
Amount: $150,000/yr
Term: 2003-2005
Immunobiology of Pancreatic Islet Xenografting
Principal Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health - R01 DK45773
Amount: $132,000/yr
Term: 1998-2006
Pre-Clinical Approaches to Islet Allograft Tolerance
Principal Investigator: Ronald G. Gill, PhD
Source: Juvenile Diabetes Foundation International
Amount: $123,847/yr
Term: 2002-2005
Defining Diabetes in Youth - Ethnic Diversity in Three Populations
Principal Investigator: Richard F. Hamman, MD, DrPH
Source: National Institutes of Health - 5R01 DK059184-03
Amount: $728,517
Term: 2004-2005
Western Registry Grant (SEARCH)
Principal Investigator: Richard F. Hamman, MD, DrPH
Source: Centers for Disease Control and Prevention - U48 CCU815787-04
Amount: $714,085
Term: 2000-2005
Autoreactive T-Cells in the NOD Mouse
Principal Investigator: Kathryn Haskins, PhD
Source: National Institutes of Health - R01 DK50561
Amount: $206,022/yr
Term: 1996-2004
Regulatory T-Cells in the NOD Mouse
Principal Investigator: Kathryn Haskins, PhD
Source: Juvenile Diabetes Foundation International -1-2004-49
Amount: $152,020/yr
Term: 2004-2007
Role of CD40 in the Regulation of Autoreactive T-Cells
Principal Investigator: Kathryn Haskins, PhD
Source: Juvenile Diabetes Foundation International - 1-2004-113
Amount: $152,020/yr
Term: 2004-2007
Tolerogenic APC for the Treatment of Type 1 Diabetes
Principal Investigator: Kathryn Haskins, PhD
Source: American Diabetes Association
Amount: $86,954/yr
Term: 2001-2004
Oxidative Stress in Beta Cell Destruction and Regeneration
Principal Investigator: Kathryn Haskins, PhD
Source: Juvenile Diabetes Foundation International - 5-2004-112
Amount: $45,000/yr
Term: 2004-2005
Diabetes and Endocrinology Research Center
Principal Investigator: John C. Hutton, PhD
Co-Investigators: Ronald G. Gill, PhD, Dale Wegmann, PhD, and Lori Sussel, PhD
Source: National Institutes of Health - P30 DK57516
Amount: $1,036,820/yr
Term: 2000-2005
- Administrative Core
Program Director: John C. Hutton, PhD
Deputy Director: George S. Eisenbarth, MD, PhD
Amount: $120,023/yr
Term: 2000-2005
- Animal Core
Core Director: Ronald G. Gill, PhD
Amount: $97,726/yr
Term: 2000-2005
- Islet Core
Core Director: Dale Wegmann, PhD
Amount: $40,952/yr
Term: 2000-2005
- Molecular Core
Core Director: John C. Hutton, PhD
Deputy Director: Lori Sussel, PhD
Amount: $99,674/yr
Term: 2000-2005
- Cytometry Core
Core Director: Jan Jensen, PhD
Amount: $77,201/yr
Term: 2000-2005
- Pilot and Feasibility Project
Principal Investigator: Dirk Homann, MD, PhD
Amount: $45,000/yr
Term: 2004-2005
- Pilot and Feasibility Project
Principal Investigator: Joe McCord, PhD
Amount: $45,000/yr
Term: 2004-2005
- Pilot and Feasibility Project
Principal Investigator: Alexander C. Wiseman, MD
Amount: $30,000/yr
Term: 2004-2005
- Pilot and Feasibility Project
Principal Investigator: Gongyi Zhang, PhD
Amount: $30,000/yr
Term: 2004-2005
- Pilot and Feasibility Project: Characterization of Pancreatic Pathology in Islet Auto Antibodies Positive Organ Donors
Principal Investigator: Roberto Gianani, MD
Co-Investigator: John C. Hutton, PhD
Amount: $200,000/yr
Term: 2004-2005
Development and Regeneration of the Endocrine Pancreas (Beta Cell Biology Consortium Program Grant)
Principal Investigator: John C. Hutton, PhD
Co-Investigators: Lori Sussel, PhD, and Jan Jensen, PhD
Source: National Institutes of Health - U19 DK61248
Amount: $957,037/yr
Term: 2001-2005
RIP-Phogrin/EGFP Transgenic Mouse: A Tool for Studying Pancreatic Beta Cell Embryogenesis and Function
Principal Investigator: John C. Hutton, PhD
Source: Juvenile Diabetes Foundation - 1-2001-604
Amount: $187,390/yr
Term: 2001-2004
Islet G6Pase-Related Protein: A Novel -cell Specific Target for T-Cell Mediated Autoimmunity in Type 1 Diabetes
Principal Investigator: John C. Hutton, PhD
Co-Investigator: Howard Davidson, PhD
Source: American Diabetes Association
Amount: $86,957/yr
Term: 2004-2006
Regulation of Insulin Secretion by Protein Phosphorylation
Principal Investigator: John C. Hutton, PhD
Source: National Institutes of Health - R01 DK55597
Amount: $191,609/yr
Term: 1999-2004
Mentor-Based Postdoctoral Fellowship Program
Principal Investigator: John C. Hutton, PhD
Source: American Diabetes Association
Amount: $45,000/yr
Term: 2004-2008
Proteomics Analysis of T-Cell Autoantigens in T1D2
Principal Investigator: Kathryn Haskins, PhD
Co-Investigators: John C. Hutton, PhD, and Howard Davidson, PhD
Source: National Institutes of Health - R21 AI065355
Amount: $308,000/yr
Term: 2004-2006
Morphogenetic Control of -cell Specification
Principal Investigator: Jan Jensen, PhD
Source: American Diabetes Association
Amount: $143,432/yr
Term: 2001-2006
Diabetes Research for Pediatric Endocrinologists (K12) and Fellows Training Grant (T32) [Combined Grant]
Principal Investigator: Georgeanna J. Klingensmith, MD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - 5 K12 DK063722-03 and 5 T32 DK063687-03
Amount: $288,963/yr (K12)
$174,996/yr (T32)
Term: 2002-2007
Pediatric Endocrinology Training Position: Exploration of Gene-Environment Interaction
Principal Investigator: Georgeanna J. Klingensmith, MD
Source: Juvenile Diabetes Research Foundation - 13-2002-444
Amount: $50,000/yr
Term: 2002-2005
Psychological Implications of Newborn and Early Childhood Screening for the Increased Risk of Type 1 Diabetes
Principal Investigator: Georgeanna J. Klingensmith, MD
Source: The Talofa Foundation
Amount: $35,000
Term: 2001-2006
A 24-Week Randomized, Double-Blind, Active Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rosiglitazone when Administered to Pediatric Patients with Type 2 Diabetes Mellitus
Principal Investigator: Georgeanna J. Klingensmith, MD
Source: GlaxoSmithKline
Amount: $11,943/yr
Term: 2001-2004
IRAS Family Study
Principal Investigator: Jill M. Norris, PhD
Source: National Institutes of Health, National Heart, Lung, and Blood Institute - R01 HL61019
Amount: $694,050
Term: 1999-2004
Nutritional Etiology of Pre-Diabetic Autoimmunity
Principal Investigator: Jill M. Norris, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - RO1
Amount: $830,000
Term: 1997-2005
Mechanism of CD40 T-Cell Dependent Acute Cardiac Allograft Rejection
Principal Investigator: Biagio A. Pietra, MD
Co-Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health - R01 HL67976
Amount: $225,000/yr
Term: 2001-2005
Natural History of Pre-Diabetic Autoimmunity
Principal Investigator: Marian J. Rewers, MD, PhD, MPH
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases - R01 DK32493
Amount: $ 4,052,324
Term: 1997-2006
Environmental Causes of Type 1 Diabetes (TEDDY)
Principal Investigator: Marian J. Rewers, MD, PhD, MPH
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - U01 DK63821
Amount: $3,253,203
Term: 2002-2007
Diabetes Autoimmunity Study in the Young (DAISY)
Principal Investigator: Marian J. Rewers, MD, PhD, MPH
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - RO1 DK32493
Amount: $3,111,271
Term: 1993-2006
Subclinical Heart Disease in Insulin-Dependent Diabetes; Coronary Artery Calcification in Type 1 Diabetes
Principal Investigator: Marian J. Rewers, MD, PhD, MPH
Source: National Institutes of Health, National Heart, Lung, and Blood Institute - R01 HL61753
Amount: $1,985,608
Term: 1999-2008
Genetic and Environmental Causes of Celiac Disease
Principal Investigator: Marian J. Rewers, MD, PhD, MPH
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - R01 DK50979
Amount: $1,610,342
Term: 1995-2006
Determinants of Accelerated CVD in Type 1 Diabetes
Principal Investigator: Marian J. Rewers, MD, PhD, MPH
Source: National Institutes of Health, National Heart, Lung, and Blood Institute - RO1 HL079611
Amount: $1,536,537
Term: 2004-2008
Molecular Dissection of Immunoregulatory Function
Principal Investigator: Robert Scheinman, PhD
Co-Investigator: Dale Wegmann, PhD
Source: National Institutes of Health - R21 DK062820
Amount: $100,000/yr
Term: 2003-2005
The Role of Gata4 in Regulating Exocrine Pancreas Development
Principal Investigator: Lori Sussel, PhD
Source: National Institutes of Health - R01DK641461
Amount: $176,000/yr
Term: 2003-2008
Core Center Grant/Transgenic Mouse Core
Principal Investigator: Diego Restrepo, PhD
Co-Investigator: Lori Sussel, PhD
Source: National Institutes of Health - P30 DC004657-01
Amount: $134,634/yr
Term: 2000-2005
Transcriptional Regulation of Exocrine Pancreas Differentiation
Principal Investigator: Lori Sussel, PhD
Source: National Institutes of Health - R21DK061151
Amount: $100,000/yr
Term: 2001-2003
American Diabetes Association Career Development Award: The Role of Nkx2.2 in the Development of the Pancreatic Beta Cell
Principal Investigator: Lori Sussel, PhD
Source: American Diabetes Association
Amount: $87,000/yr
Term: 2000-2003
Adenoviral Vector Manipulation of T-Cell Pathogenesis in NOD Mice
Principal Investigator: Dale Wegmann, PhD
Source: American Diabetes Association
Amount: $100,000/yr
Term: 2001-2004
Exploring Diabetes and Depression in Youth
Principal Investigator: Philippe Weintraub, MD
Source: National Institutes of Health - RO1MH068126
Amount: $6,976/yr
Term: 2002-2005
Treatment Alternatives in Pediatric Type 2 Diabetes and Population-Based Prevention Strategies (TODAY)
Principal Investigator: Philip S. Zeitler, MD, PhD
Co-Investigator: Georgeanna T. Klingensmith, MD
Source: National Institutes of Health - 1 U01DK061242-03
Amount: $469,139
Term: 2001-2008
2001-2002
Regulation of Insulin-Dependent Diabetes Mellitus by NKT-Cells
Principal Investigator: Albert Bendalac, MD
Co-Investigator: Peter A. Gottlieb, MD
Source: National Institutes of Health - R01 DK061724
Amount: $20,020
Term: 2002-2007
SPORE in Lung Cancer Project 5: Neuropeptide Degradation and Pulmonary Carcinogenesis
Principal Investigator: Paul A. Bunn, MD
Co-Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health - P50 CA58487
Amount: $87,000/yr
Term: 1995-2002
Diabetes Prevention Trial-1 (DPT-1) Clinical Center Subcontract
Principal Investigator: H. Peter Chase, MD
Source: National Institutes of Health, Juvenile Diabetes Foundation, American Diabetes Association - 5 U01 DK60782
Amount: $202,162/yr
Term: 1993-2002
Glucose Sensors in Children with Type 1 Diabetes
Principal Investigator: H. Peter Chase, MD
Source: National Institutes of Health - 1 U10 HD041919
Amount: $379,909 (first year)
Term: 2001-2006
DPT-1/TrialNet
Principal Investigator: H. Peter Chase, MD
Source: National Institutes of Health - 1 U01 DK060782
Amount: $641,905 (first year)
Term: 2001-2008
In Vivo NOD Evaluation of a "Pathogenic" Insulin Peptide
Principal Investigator: George S. Eisenbarth, MD, PhD
Co-Investigator: Dale Wegmann, PhD
Source: National Institutes of Health - R01 DK55969
Amount: $189,241/yr
Term: 1998-2003
Mentor-Based Fellowship
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: American Diabetes Association
Amount: $35,000/yr
Term: 1998-2005
Collaborative Network for Clinical Research in Immune Tolerance
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health - N01 AI 95380
Amount: $41,207/yr
Term: 1999-2006
Core Autoantibody Determination Laboratory for Immune Tolerance Network
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health - N01 AI 95380
Amount: $151,000/yr
Term: 1999-2006
Blum Kovler Fellowship
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: Blum Kovler Foundation
Amount: $33,000/yr
Term: 2001-2003
Antibodies to Recombinant Autoantigens: Prediction/Immunogenetics
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health - R01 AI39213
Amount: $91,768
Term: 2001-2005
Multiple Autoantigens/Multiple Epitopes of Pre-Type 1 Diabetes Mellitus
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health - 2 R01 DK 32083-20A2
Amount: $166,250/yr
Term: 2001-2005
Virginia Mason/UCD Autoimmune Prevention Center
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health - AI50864-01 U19 ZAI1
Amount: $1,849,022/yr
Term: 2001-2006
International Congress of the Immunology of Diabetes Society
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: Juvenile Diabetes Research Foundation International
Amount: $15,000
Term: 2002-2003
International Congress of the Immunology of Diabetes Society
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health - R13 DK62745
Amount: $17,000
Term: 2002-2003
Modeling and Detecting Pathogens of Islet Autoimmunity
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health - R01 DK62718
Amount: $100,000/yr
Term: 2002-2006
Diabetes Prevention Trial/TrialNet HLA Laboratory Subcontract
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health - U01 DK 46639-03
Amount: $485,222
Term: 2002-2008
Positional Cloning of a Type 1 Diabetes Susceptibility Gene on Human Chromosome 10
Principal Investigator: Pamela R. Fain, PhD
Source: Juvenile Diabetes Foundation International - 198203
Amount: $200,000/yr
Term: 1998-2001
Genetic Epidemiology of Lung Cancer
Principal Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health - 1 R01 CA76293-0
Amount: $99,900/yr
Term: 1999-2003
Immunogenetics of Type 1 Diabetes in a Bedouin Arab Family
Principal Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health - 1 R01 DK57538-01
Amount: $250,000/yr
Term: 2000-2005
Positional Cloning of a Type 1 Diabetes Susceptibility Gene on Human Chromosome 10
Principal Investigator: Pamela R. Fain, PhD
Source: Juvenile Diabetes Foundation International - 198203
Amount: $450,000
Term: 2001-2003
Efficacy and Safety of Inhaled Compared with Subcutaneous Human Insulin in Type 1 Diabetes
Principal Investigator: Satish K. Garg, MD
Source: Pfizer, Inc.
Amount: $73,000
Term: 1998-2001
Long-Term Safety of Inhaled Insulin
Principal Investigator: Satish K. Garg, MD
Source: Pfizer, Inc.
Amount: $51,188
Term: 1999-2001
Comparison Between Human Regular and Humalog Insulin in Type 1 Diabetes
Principal Investigator: Satish K. Garg, MD
Source: Eli Lilly & Company
Amount: $800,000
Term: 1999-2004
EBCT in Type 1 Diabetes (Subclinical Heart Disease in Insulin-Dependent Diabetes Mellitus)
Principal Investigator: Satish K. Garg, MD
Source: National Institutes of Health - 1 R01 HL61753-01
Amount: $447,192
Term: 1999-2004
A Multicenter Study of Calibration/Calibration Stability and Accuracy and Precision Measurements in a Diabetic Population Using the IM 100P Device
Principal Investigator: Satish K. Garg, MD
Source: Instrumentation Metrics
Amount: $238,493
Term: 2000-2001
Clinical Evaluation of the Fast AIRE Glucose Monitoring System
Principal Investigator: Satish K. Garg, MD
Source: Life Scan
Amount: $35,500
Term: 2000-2001
Double-Blind, Randomized Study of Actos 45mg vs. Actos 30mg in Type 2 Diabetes
Principal Investigator: Satish K. Garg, MD
Source: Takeda Pharmaceuticals, Inc.
Amount: $51,380
Term: 2000-2002
Aventis HOE 901/4016
Principal Investigator: Satish K. Garg, MD
Co-Investigator: William E. Jackson, MD
Source: Quintiles/Aventis
Term: 2001-2006
Effect on Glucose Control (HbA1c) of AC2993 Given Twice Daily in Subjects with Type 2 Diabetes
Principal Investigator: Satish K. Garg, MD
Source: Amylin Pharmaceuticals
Amount: $46,956
Term: 2002-2003
A Study of the Safety and Effectiveness of the DexCom Continuous Glucose Monitor
Principal Investigator: Satish K. Garg, MD
Source: DexCom, Inc.
Amount: $116,065
Term: 2002-2004
Catalyst System Evaluation Patient Use Protocol
Principal Investigator: Satish K. Garg, MD
Source: Bayer Corporation
Amount: $27,096
Term: 2002-2004
Clinitek Status Urinalysis Performance Evaluation
Principal Investigator: Satish K. Garg, MD
Source: Bayer Corporation
Amount: $26,460/yr
Term: 2002-2004
Safety of Pramlintide Treatment Employing Pramlintide in Type 1 Diabetes
Principal Investigator: Satish K. Garg, MD
Source: Amylin Pharmaceuticals
Amount: $76,957
Term: 2002-2004
Multicenter Study of Long-Term Safety of Pramlintide in Type 1 Diabetes Completing Protocol 137-150
Principal Investigator: Satish K. Garg, MD
Source: Amylin Pharmaceuticals
Amount: $39,301
Term: 2002-2005
Study of Protocol 2993-115 to Examine the Long-Term Effect on Glucose Control of AC2993
Principal Investigator: Satish K. Garg, MD
Source: Amylin Pharmaceuticals
Amount: $44,260
Term: 2003-2005
T-Cell-Mediated Injury to Islet Allografts
Principal Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health - R01 DK33470
Amount: $204,341/yr
Term: 1998-2001
Reversal of Diabetes by Islet Transplantation
Principal Investigator: Ronald G. Gill, PhD
Co-Investigator: Dale Wegmann, PhD
Source: National Institutes of Health - R01 DK 33470
Amount: $294,450/yr
Term: 1998-2002
Immunobiology of Pancreatic Islet Xenografting
Principal Investigator: Ronald G. Gill, PhD
Co-Investigator: Dale Wegmann, PhD
Source: National Institutes of Health - R01 DK45773
Amount: $202,429/yr
Term: 1998-2003
Cellular Immunity to Micro-Encapsulated Islet Allografts
Principal Investigator: Ronald G. Gill, PhD
Source: Juvenile Diabetes Foundation International
Amount: $300,000
Term: 1999-2001
Generation of Alloreactive CD4+ T-Cell Receptor Transgenic Mice
Principal Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health - R21 DK59973
Amount: $100,000/yr
Term: 2001
Islet Cell Resource Center
Principal Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health - 1 U42 RR16599-01
Amount: $755,000/yr
Term: 2001-2006
Analysis of Gata4 and Gata6 Function during Embryonic Pancreas Development
Postdoctoral Fellow: Devorah Goldman, PhD
Sponsor: Lori Sussel, PhD
Source: Juvenile Diabetes Foundation
Amount: $31,416/yr
Term: 2001-2002
Immunotherapy Trial in New Onset Type 1 Diabetes
Principal Investigator: Peter A. Gottlieb, MD
Source: National Institutes of Health - RO1 DK59097
Amount: $250,000/yr
Term: 2000-2003
Potential Efficacy of an Altered Peptide Ligand of Insulin in New Onset Type 1 Diabetes Patients
Principal Investigator: Peter A. Gottlieb, MD
Source: Neurocrine Biosciences - NBI 6024-0003
Amount: $200,000
Term: 2001-2003
Human TCR/HLA Transgenic Mice to Prevent Type 1 Diabetes Mellitus
Principal Investigator: Peter A. Gottlieb, MD
Source: National Institutes of Health - R21 DK63518
Amount: $170,000
Term: 2002-2004
DQB1*0602 Relatives: Mechanisms Conferring Diabetes Protection
Principal Investigator: Carla J. Greenbaum, MD
Co-Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health - R01 AI44431
Amount: $66,950/yr
Term: 1999-2003
Regulatory T-Cells in Autoimmune Disease
Principal Investigator: David Hafler, MD
Co-Investigator: Peter A. Gottlieb, MD
Source: National Institutes of Health - U01 DK61926
Amount: $18,875
Term: 2001-2006
Defining Diabetes in Youth - Ethnic Diversity in Three Populations
Principal Investigator: Richard Hamman, MD, DrPH
Co-Investigator: Philip S. Zeitler, MD, PhD
Source: National Institutes of Health -1R01DK059184
Amount: $500,000/yr
Term: 2002-2005
Western Registry of Diabetes in Youth
Principal Investigator: Richard Hamman, MD, DrPH
Co-Investigator: Georgeanna J. Klingensmith, MD
Source: Centers for Disease Control and Prevention - CCU819241-01U48
Amount: $741,034/yr
Term: 2000-2004
Training Program in Immunology
Principal Investigator: Kathryn Haskins, PhD
Source: National Institutes of Health - 5T32A1007405
Amount: $912,379
Term: 1996-2001
Autoreactive T-Cells in the NOD Mouse
Principal Investigator: Kathryn Haskins, PhD
Source: National Institutes of Health - R01 DK50561
Amount: $948,630
Term: 1996-2004
Immunoregulation in the NOD Mouse
Principal Investigator: Kathryn Haskins, PhD
Source: National Institutes of Health - R01 A1/DK44482
Amount: $723,745
Term: 1998-2001
The Role of Amylin in Autoimmune Diabetes
Principal Investigator: Kathryn Haskins, PhD
Source: American Diabetes Association
Amount: $150,000/yr
Term: 1998-2001
T-Cell Antigens in Autoimmune Diabetes
Principal Investigator: Kathryn Haskins, PhD
Source: Juvenile Diabetes Foundation International -1-2000-322
Amount: $450,000
Term: 2000-2003
Manipulation of Complement Activities as a Novel Therapeutic Strategy for Autoimmune Insulin-Dependent Diabetes Mellitus
Principal Investigator: V. Michael Holers, MD
Co-Investigator: Ronald G. Gill, PhD
Source: Juvenile Diabetes Foundation International
Amount: $90,570
Term: 1999-2001
Pancreatic Islet Glucose 6 Phosphatase-Related Protein: Its Role in Metabolic and Secretory Dysfunction in the Pancreatic B-Cell
Principal Investigator: John C. Hutton, PhD
Source: American Diabetes Association
Amount: $86,789/yr
Term: 1999-2002
Regulation of Insulin Secretion by Protein Phosphorylation
Principal Investigator: John C. Hutton, PhD
Source: National Institutes of Health - R01 DK55597-03
Amount: $183,159/yr
Term: 1999-2004
Mentor-Based Postdoctoral Fellowship Program
Principal Investigator: John C. Hutton, PhD
Source: American Diabetes Association
Amount: $35,000/yr
Term: 2000-2004
Diabetes and Endocrinology Research Center
Principal Investigator: John C. Hutton, PhD
Co-Investigators: George S. Eisenbarth, MD, PhD, Ronald G. Gill, PhD, Marian Rewers, MD, PhD, MPH, and Dale Wegmann, PhD
Source: National Institutes of Health - P30 DK57516
Amount: $682,119/yr
Term: 2000-2005
- Administrative Core
Program Director: John C. Hutton, PhD
Deputy Director: George S. Eisenbarth, MD, PhD
Amount: $103,793/yr
Term: 2000-2005
- Animal Core
Core Director: Ronald G. Gill, PhD
Amount: $88,704/yr
Term: 2000-2005
- Islet Core
Core Director: Dale Wegmann, PhD
Amount: $55,033
Term: 2000-2005
- Molecular Core
Core Director: John C. Hutton, PhD
Deputy Director: Lori Sussel, PhD
Amount: $93,530/yr
Term: 2000-2005
- Cytometry Core
Core Director: Jan Jensen, PhD
Amount: $83,225
Term: 2000-2005
- Pilot and Feasibility Project
Principal Investigator: Peter A. Gottlieb, MD
Amount: $25,000
Term: 2000-2001
- Pilot and Feasibility Project
Co-Principal Investigators: William E. Jackson, MD, and Krzysztof Cios, PhD
Amount: $90,000
Term: 2001-2002
- Pilot and Feasibility Project: Generation of Phogrin-Specific T-Cell Receptor Transgenic Mice
Principal Investigator: Katalin Kelemen, MD, PhD
Amount: $25,000
Term: 2000-2001
- Pilot and Feasibility Project: Randomized Controlled Trial of Metformin for Treatment of Insulin Resistance in Obese Adolescents
Principal Investigator: Kathryn Love-Osborne, MD
Co-Investigator: Philip S. Zeitler, MD, PhD
Amount: $46,800/yr
Term: 2001-2003
- Pilot and Feasibility Project: RNA Profise Analysis of Pancreatic Islet Development
Principal Investigator: Mark Geraci, MD
Co-Investigator: John C. Hutton, PhD
Amount: $100,000
Term: 2001-2002
- Pilot and Feasibility Project: Survival and Function of Encapsulated Mouse Islets
Principal Investigator: Kathryn Haskins, PhD
Co-Investigator: John C. Hutton, PhD
Amount: $100,000
Term: 2002-2003
- Vesicular Traffic and Regulated Secretion in C. Elegans
Principal Investigator: John C. Hutton, PhD
Source: National Institutes of Health - R21 DK60861
Amount: $100,000
Term: 2001-2003
Beta Cell Biology Consortium - Project 1 of 2
Principal Investigator: John C. Hutton, PhD
Co-Investigator: Lori Sussel, PhD
Source: National Institutes of Health - U19 DK61248
Amount: $164,948/yr
Term: 2001-2004
Development and Regeneration of the Endocrine Pancreas (Beta Cell Consortium Program Grant)
Principal Investigator: John C. Hutton, PhD
Source: National Institutes of Health - U19 DK61248
Amount: $957,037
Term: 2001-2004
RIP-Phogrin/EGFP Transgenic Mouse: A Tool for Studying Pancreatic Beta Cell Embryogenesis and Function
Principal Investigator: John C. Hutton, PhD
Source: Juvenile Diabetes Foundation - 1-2001-604
Amount: $184,530
Term: 2001-2004
Protein Kinase C Inhibitor B-Diabetic Retinopathy Study
Principal Investigator: William E. Jackson, MD
Source: Lilly Research Laboratories - PKC-DRS
Amount: $142,703
Term: 1998-2001
Protein Kinase C Inhibitor B-Diabetic Macular Edema Study
Principal Investigator: William E. Jackson, MD
Source: Lilly Research Laboratories - BYA-MC-MBBK
Amount: $413,000
Term: 1998-2002
Protein Kinase C Inhibitor B-Diabetic Retinopathy Study
Principal Investigator: William E. Jackson, MD
Source: Lilly Research Laboratories - PKC-DRS2
Amount: $110,462
Term: 2001-2005
A 24-Week Randomized, Double-Blind, Active Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rosiglitazone when Administered to Pediatric Patients with Type 2 Diabetes Mellitus
Principal Investigator: Georgeanna J. Klingensmith, MD
Co-Investigators: H. Peter Chase, MD, Philippe Walravens, MD, and Carolyn Banion, RN, MS, PNP
Source: GlaxoSmithKline
Amount: $11,943
Term: 2001-2002
Clinical Evaluation of Freestyle Blood Glucose Monitoring System Using Capillary Blood from Arm and Finger
Principal Investigator: Georgeanna J. Klingensmith, MD
Source: Therasense, Inc.
Amount: $6,930
Term: 2001-2002
Home-Testing of a New Glucose Test Strip for the Precision XtraTM Advanced Diabetes Management System by Lay Users
Principal Investigator: Georgeanna J. Klingensmith, MD
Source: Abbott Laboratories Medisense Products
Amount: $12,900
Term: 2001-2002
Psychological Implications of Newborn and Early Childhood Screening for the Increased Risk of Type 1 Diabetes
Principal Investigator: Georgeanna J. Klingensmith, MD
Source: The Talofa Foundation
Amount: $40,909
Term: 2001-2004
Pediatric Endocrinology Training Position
Principal Investigator: Georgeanna J. Klingensmith, MD
Source: Juvenile Diabetes Research Foundation - 13-2002-444
Amount: $50,000/yr
Term: 2002-2005
Diabetes Research for Pediatric Endocrinologists (Combined application for training of pediatric endocrinology fellows and junior pediatric endocrinology faculty)
Principal Investigator: Georgeanna J. Klingensmith, MD
Source: National Institutes of Health
Amount: $719,516 - 1 T32 DK63687-01
$1,213,702 - 1 K12 DK63722-01
Term: 2002-2007
Denver Autoimmunity Center of Excellence
Principal Investigator: Brian Kotzin, MD
Co-Investigators: Pamela R. Fain, PhD, George S. Eisenbarth, MD, PhD, and Peter A. Gottlieb, MD
Source: National Institutes of Health, National Institute of Allergy and Infectious Diseases - U19AI46374
Amount: $2,815,727
Term: 1999-2003
MHC-Peptide Tetramers in Type 1 Diabetes
Principal Investigator: Brian Kotzin, MD
Co-Investigator: Peter A. Gottlieb, MD
Source: National Institutes of Health - U19 AI46374
Amount: $150,000
Term: 1999-2003
Nutritional Etiology of Prediabetic Autoimmunity
Principal Investigator: Jill Norris, PhD
Co-Investigator: Marian Rewers, MD, PhD, MPH
Source: National Institutes of Health - 5R01DK049654
Amount: $851,192
Term: 1997-2001
Growth Impairment and Adrenal Suppression in Children Receiving High-Dose Inhaled Steroid Therapy for Asthma
Principal Investigator: Keith Paull, MD
Co-Investigator: Philip S. Zeitler, MD, PhD
Source: Genentech Institute for Growth
Amount: $50,000/yr
Term: 2002-2003
Mechanism of CD40 T-Cell Dependent Acute Cardiac Allograft Rejection
Principal Investigator: Biagio A. Pietra, MD
Co-Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health - R01 HL67976-01
Amount: $225,000/yr
Term: 2001-2006
Natural History of Prediabetic Autoimmunity
Principal Investigator: Marian Rewers, MD, PhD, MPH
Co-Investigators: George S. Eisenbarth, MD, PhD, and Georgeanna J. Klingensmith, MD
Source: National Institutes of Health - R01DK32493
Amount: $2,000,315
Term: 1993-2001
Genetic and Environmental Causes of Celiac Disease
Principal Investigator: Marian Rewers, MD, PhD, MPH
Co-Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health - 1R01 DK50979-01
Amount: $27,765
Term: 2001-2004
Insulin Resistance Atherosclerosis Family Study
Principal Investigator: Marian Rewers, MD, PhD, MPH
Source: National Institutes of Health - 5U01HL047892
Amount: $439,671/yr
Term: 1999-2004
Subclinical Heart Disease in Insulin-Dependent Diabetes
Principal Investigator: Marian Rewers, MD, PhD, MPH
Co-Investigator: Satish K. Garg, MD
Source: National Institutes of Health - 5R01HL061753
Amount: $671,690/yr
Term: 1999-2004
NOD T-Cell Receptors for Specific Islet Autoantigens
Principal Investigator: Eric Simone, MD
Source: National Institutes of Health - 5R01AI044466
Amount: $607,976
Term: 1998-2001
Autoimmune T-Cell Responses to Novel Peptides in Insulin-Dependent Diabetes Mellitus
Principal Investigator: Grete Sonderstrup, MD
Project Leader: Peter A. Gottlieb, MD
Co-Investigators: George S. Eisenbarth, MD, PhD, and Dale Wegmann, PhD
Source: National Institutes of Health -1 P01 DK55364-01
Amount: $2,426,655
Term: 1998-2001
Mapping of Vitiligo Susceptibility Genes
Principal Investigator: Richard A. Spritz, MD
Co-Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health, National Institute of Arthritis, Musculoskeletal and Skin Diseases - AR45584
Amount: $1,436,489
Term: 1999-2003
UCD/Barbara Davis Center Start-Up Package
Principal Investigator: Lori Sussel, PhD
Source: University of Colorado Denver
Amount: $380,000
Term: 1998-2001
American Diabetes Association Career Development Award: The Role of Nkx2.2 in the Development of the Pancreatic Beta Cell
Principal Investigator: Lori Sussel, PhD
Source: American Diabetes Association
Amount: $87,000/yr
Term: 2000-2003
Core Center Grant/Transgenic Mouse Core
Principal Investigator: Diego Restrepo, PhD
Co-Investigator: Lori Sussel, PhD
Source: National Institutes of Health - P30 DC004657-01
Amount: $134,634/yr
Term: 2000-2004
Transcriptional Regulation of Exocrine Pancreas Differentiation
Principal Investigator: Lori Sussel, PhD
Source: National Institutes of Health - R21DK061151
Amount: $100,000/yr
Term: 2001-2003
Metformin Insulin Compared to Insulin Monotherapy for Treatment of Adolescents with Type 2 Diabetes
Principal Investigator: Philippe Walravens, MD
Source: Bristol-Meyers Squibb US Pharmaceuticals
Amount: $70,000
Term: 1997-2001
Efficacy and Safety of Inhaled Insulin
Principal Investigator: Philippe Walravens, MD
Source: Pfizer, Inc.
Amount: $58,400
Term: 1999-2001
Long-Term Safety of Inhaled Insulin - Extension of Therapy
Principal Investigator: Philippe Walravens, MD
Source: Pfizer, Inc.
Amount: $128,824
Term: 1999-2002
Adenoviral Vector Manipulation of T-Cell Pathogenesis in NOD Mice
Principal Investigator: Dale Wegmann, PhD
Source: American Diabetes Association
Amount: $100,000/yr
Term: 2001-2004
Treatment Alternatives in Pediatric Type 2 Diabetes
Principal Investigator: Philip S. Zeitler, MD, PhD
Co-Investigator: Georgeanna J. Klingensmith, MD
Source: National Institutes of Health - 1U01 DK061242-01
Amount: $350,000/yr
Term: 2002-2009
The Physiology of Growth Hormone-Releasing Hormone (GHRH) in Breast Cancer
Principal Investigator: Philip S. Zeitler, MD, PhD
Source: US Department of Defense Breast Cancer Research Program - BC990426
Amount: $74,954/yr
Term: 2000-2003
1999-2000
Diabetes Prevention Trial-1 (DPT-1) Clinical Center Subcontract
Principal Investigator: H. Peter Chase, MD
Source: National Institutes of Health
Amount: $202,162
Term: 1993-2000
Effect of BCG Vaccination on New-Onset Insulin Dependent Diabetes Mellitus: A Randomized Clinical Study
Principal Investigator: H. Peter Chase, MD
Co-Investigator: Georgeanna Klingensmith, MD
Source: Organon Teknika
Amount: $94,000
Term: 1994-2000
American Diabetes Association/Diabetes Prevention Trial #1 Study Group
Principal Investigator: H. Peter Chase, MD
Source: American Diabetes Association
Amount: $45,000
Term: 1997-1999
Antioxidant Trial
Principal Investigator: H. Peter Chase, MD
Source: Life Force
Amount: $159,520
Term: 1997-2000
Denver Autoimmunity Center of Excellence
Principal Investigator: Brian Kotzin, MD
Co-Investigators: Pamela R. Fain, PhD, George S. Eisenbarth, MD, PhD and Peter A. Gottlieb, MD
Source: National Institutes of Health
Amount: $4,406,581
Term: 1999-2004
Multiple Autoantigens of Pre-Type 1 DM
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health
Amount: $492,434
Term: 1992-2000
Mentor-Based Fellowship
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: American Diabetes Association
Amount: $275,000
Term: 1992-2001
Diabetes Prevention Trial HLA Laboratory Subcontract
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health
Amount: $452,283
Term: 1993-2000
Blum Kovler Fellowship
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: Blum Kovler
Amount: $153,969
Term: 1996-2000
Antibodies to Recombinant Autoantigens: Prediction/Immunogenetics
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health
Amount: $1,186,775
Term: 1996-2001
Autoantibody Research Project
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: Bayer Corporation
Amount: $110,000
Term: 1996-2000
Juvenile Diabetes Foundation Fellowship Award - Eric Simone, MD
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: Juvenile Diabetes Foundation
Amount: $64,000
Term: 1997-1999
Biorobot 9600/ABI Prism Sequinator
Principal Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health
Amount: $140,394
Term: 1998-1999
In Vivo NOD Evaluation of a "Pathogenic" Insulin Peptide
Principal Investigator: George S. Eisenbarth, MD, PhD
Co-Investigator: Dale Wegmann, PhD
Source: National Institutes of Health
Amount: $338,248
Term: 1998-2001
DQB1*0602 Relatives: Mechanisms Conferring Diabetes Protection
Principal Investigator: Carla J. Greenbaum, MD
Co-Investigator: George S. Eisenbarth, MD, PhD
Source: National Institutes of Health
Amount: $245,423
Term: 1999-2002
SPORE in Lung Cancer Project 5 (Miller): Neuropeptide Degradation and Pulmonary Carcinogenesis
Principal Investigator: Paul A. Bunn, MD
Co-Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health
Amount: $131,370/yr
Term: 1995-2002
Mapping of Vitiligo Susceptibility Genes
Principal Investigator: Richard A. Spritz, MD
Co-Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health
Amount: $561,604
Term: 1999-2003
A Positional Candidate Approach to Identifying a Diabetes Susceptibility Gene on Chromosome 10
Principal Investigator: Pamela R. Fain, PhD
Source: American Diabetes Association
Amount: $150,000
Term: 1997-1999
Genetic Epidemiology of Lung Cancer
Principal Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health
Amount: $150,854/yr
Term: 1999-2003
Immunogenetics of Type 1 Diabetes in a Bedouin Arab Family
Principal Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health
Amount: $1,420,750
Term: 2000-2003
Positional Cloning of a Type 1 Diabetes Susceptibility Gene on Human Chromosome 10
Principal Investigator: Pamela R. Fain, PhD
Source: Juvenile Diabetes Foundation International
Amount: $200,000
Term: 1998-2001
Positional Cloning of a Type 1 Diabetes Susceptibility Gene on Human Chromosome 10
Principal Investigator: Pamela R. Fain, PhD
Source: Juvenile Diabetes Foundation International
Amount: $450,000
Term: 2001-2003
Zopolrestat in Normotensive Type 1 Diabetic Subjects
Principal Investigator: Satish Garg, MD
Source: Pfizer, Inc.
Amount: $68,000
Term: 1996-1999
Multi-Center Trials of Zopolrestat in Ameliorating Early Diabetic Nephropathy
Principal Investigators: Satish Garg, MD and Peter A. Gottlieb, MD
Source: Pfizer, Inc.
Amount: $100,000
Term: 1997-1999
Multi-Center Trials of Zopolrestat in Ameliorating and Peripheral Diabetic Neuropathy
Principal Investigator: Satish Garg, MD
Co-Investigator: Peter A. Gottlieb, MD
Source: Pfizer, Inc.
Amount: $107,943
Term: 1998-2000
New Nasal Insulin in Type 1 Diabetes
Principal Investigator: Satish Garg, MD
Source: Pfizer Inc.
Amount: $100,000
Term: 1998-2000
Efficacy and Safety of Inhaled Compared with Subcutaneous Human Insulin in Type 1 Diabetes
Principal Investigator: Satish Garg, MD
Source: Pfizer, Inc.
Amount: $55,048
Term: 1998-2001
Long-Term Safety of Inhaled Insulin
Principal Investigator: Satish Garg, MD
Source: Pfizer, Inc.
Amount: $51,188
Term: 1999-2001
Comparison Between Human Regular and Humalog Insulin in Type 1 Diabetes
Principal Investigator: Satish Garg, MD
Source: Eli Lilly & Company
Amount: $800,000
Term: 1999-2004
Double-Blind, Randomized Study of Actos 45mg vs. Actos 30mg in Type 2 Diabetes
Principal Investigator: Satish Garg, MD
Source: Takeda Pharmaceuticals, Inc.
Amount: $51,380
Term: 2000-2002
Clinical Evaluation of the Fast AIRE Glucose Monitoring System
Principal Investigator: Satish Garg, MD
Source: Life Scan
Amount: $35,500
Term: 2000-2001
A Multi-Center Study of Calibration/Calibration Stability and Accuracy and Precision Measurements in a Diabetic Population Using the IM 100P Device
Principal Investigator: Satish Garg, MD
Source: Instrumentation Metrics
Amount: $238,493
Term: 2000-2001
Manipulation of Complement Activities as a Novel Therapeutic Strategy for Autoimmune IDDM
Principal Investigator: V. Michael Hollers, MD
Co-Investigator: Ronald G. Gill, PhD
Source: Juvenile Diabetes Foundation International
Amount: $90,570
Term: 1999-2001
Reversal of Diabetes by Islet Transplantation
Principal Investigator: Ronald G. Gill, PhD
Co-Investigator: Dale Wegmann, PhD
Source: National Institutes of Health
Amount: $294,450/yr
Term: 1998-2002
Cellular Immunity to Micro-Encapsulated Islet Allografts
Principal Investigator: Ronald G. Gill, PhD
Source: Juvenile Diabetes Foundation International
Amount: $300,000
Term: 1999-2001
Immunobiology of Encapsulated Neonatal Porcine Xenografts
Principal Investigator: Ronald G. Gill, PhD
Source: Juvenile Diabetes Foundation
Amount: $196,770
Term: 1997-1999
Immunobiology of Pancreatic Islet Xenografting
Principal Investigator: Ronald G. Gill, PhD
Co-Investigator: Dale Wegmann, PhD
Source: National Institutes of Health
Amount: $185,251/yr
Term: 1998-2003
T-Cell-Mediated Injury to Islet Allografts
Principal Investigator: Ronald G. Gill, PhD
Source: National Institutes of Health
Amount: $204,341/yr
Term: 1998-2001
Autoimmune T-Cell Responses to Novel Peptides in IDDM
Principal Investigator: Grete Sonderstrup, MD
Project Leader: Peter A. Gottlieb, MD
Co-Investigators: George S. Eisenbarth, MD, PhD and Dale Wegmann, PhD
Source: National Institutes of Health
Amount: $2,426,655
Term: 1998-2001
Diabetes Endocrine Research Center Pilot and Feasibility Grant
Principal Investigator: Peter A. Gottlieb, MD
Source: National Institutes of Health
Amount: $25,000
Term: 2000-2001
Autoreactive T-Cells in the NOD Mouse
Principal Investigator: Kathryn Haskins, PhD
Source: National Institutes of Health
Amount: $948,630
Term: 1996-2000
Training Program in Immunology
Principal Investigator: Kathryn Haskins, PhD
Source: National Institutes of Health
Amount: $912,379
Term: 1996-2001
Identification of Islet Beta Cell Antigens through RNA Differential Display
Principal Investigator: Kathryn Haskins, PhD
Source: Juvenile Diabetes Foundation International
Amount: $200,000
Term: 1998-2000
The Role of Amylin in Autoimmune Diabetes
Principal Investigator: Kathryn Haskins, PhD
Source: American Diabetes Association
Amount: $150,000
Term: 1998-2000
Immunoregulation in the NOD Mouse
Principal Investigator: Kathryn Haskins, PhD
Source: National Institutes of Health
Amount: $723,745
Term: 1998-2001
T-Cell Antigens in Autoimmune Diabetes
Principal Investigator: Kathryn Haskins, PhD
Source: National Institutes of Health
Amount: $450,000
Term: 2000-2003
Cloning of the Molecular Targets of Cell Mediated Autoimmunity in Type 1 Diabetes
Principal Investigator: John C. Hutton, PhD
Source: National Institutes of Health
Amount: $547,160
Term: 1996-2000
Juvenile Diabetes Foundation Fellowship Grant - Christina Wasmeier, PhD
Principal Investigator: John C. Hutton, PhD
Source: Juvenile Diabetes Foundation
Amount: $60,000
Term: 1997-1999
Mentor-Based Postdoctoral Fellowship Program
Principal Investigator: John C. Hutton, PhD
Source: American Diabetes Association
Amount: $140,000
Term: 2000-2004
Molecular Dynamics Storm 860 Imager
Principal Investigator: John C. Hutton, PhD
Source: National Institutes of Health
Amount: $86,000
Term: 1998-1999
Determinant Spreading and the Progression of Cell Mediated Autoimmunity in Type 1 Diabetes: Studies with the Protein Tyrosine Phosphatase (PTP) Related Proteins (IA-2ß) and ICA512 (IA-2)
Principal Investigator: John C. Hutton, PhD
Co-Investigator: Dale Wegmann, PhD
Source: Juvenile Diabetes Foundation
Amount: $181,818
Term: 1998-2000
Pancreatic Islet Glucose 6 Phosphatase Related Protein: Its Role in Metabolic and Secretory Dysfunction in the Pancreatic B Cell
Principal Investigator: John C. Hutton, PhD
Source: American Diabetes Association
Amount: $299,595
Term: 1999-2002
Regulation of Insulin Secretion by Protein Phosphorylation
Principal Investigator: John C. Hutton, PhD
Source: National Institutes of Health
Amount: $1,415,336
Term: 1999-2004
Diabetes and Endocrine Research Center
Principal Investigator: John C. Hutton, PhD
Co-Investigators: George S. Eisenbarth, MD, PhD, Ronald G. Gill, PhD, Marian Rewers, MD, PhD, MPH and Dale Wegmann, PhD
Source: National Institutes of Health
Amount: $3,675,051
Term: 2000-2005
Protein Kinase C Inhibitor B-Diabetic Macular Edema Study
Principal Investigator: William E. Jackson, MD
Source: Lilly Research Laboratories
Amount: $413,000
Term: 1998-2002
Protein Kinase C Inhibitor B-Diabetic Retinopathy Study (PKC-DRS)
Principal Investigator: William E. Jackson, MD
Source: Lilly Research Laboratories
Amount: $142,703
Term: 1998-2001
Ocular Echography Unit
Principal Investigator: William E. Jackson, MD
Source: Donation from Ms. Debra Ordway
Term: 2000
Diabetes Endocrine Research Center Pilot and Feasibility Grant
Principal Investigator: Katalin Kelemen, MD, PhD
Source: National Institutes of Health
Amount: $25,000
Term: 2000-2001
Remote Data Management Technology Evolution
Principal Investigator: Georgeanna J. Klingensmith, MD
Source: Medisense, Inc.
Amount: $12,000
Term: 1998-1999
Insulin Resistance of Atherosclerosis Study
Principal Investigator: Marian Rewers, MD, PhD, MPH
Source: National Institutes of Health
Amount: $1,698,524
Term: 1991-2000
Natural History of Pre-Diabetic Autoimmunity
Principal Investigator: Marian Rewers, MD, PhD, MPH
Co-Investigators: George S. Eisenbarth, MD, PhD and Georgeanna J. Klingensmith, MD
Source: National Institutes of Health
Amount: $2,000,315
Term: 1993-2001
Epidemiology of Pre-Diabetic Autoimmunity in Poland
Principal Investigator: Marian Rewers, MD, PhD, MPH
Source: Fogarty International
Amount: $80,000
Term: 1995-1999
Genetic and Environmental Causes of Celiac Disease
Principal Investigator: Marian Rewers, MD, PhD, MPH
Co-Investigators: George Eisenbarth, MD, PhD, Edward Hoffenberg, MD and Ronald Sokol, MD
Source: National Institutes of Health
Amount: $610,342
Term: 1995-2000
Diabetes Mellitus in the San Luis Valley, Colorado
Principal Investigator: Richard Hamman, MD, DrPH
Co-Investigator: Marian Rewers, MD, PhD, MPH
Source: National Institutes of Health
Amount: $1,582,612
Term: 1996-1999
Glycemia and Related Mechanisms of Macrovascular Disease
Principal Investigator: Lynne Wagenknecht, MD
Co-Investigator: Marian Rewers, MD, PhD, MPH
Source: National Institutes of Health
Amount: $65,400
Term: 1997-2000
Nutritional Etiology of Pre-Diabetic Autoimmunity
Principal Investigator: Jill Norris, PhD
Co-Investigator: Marian Rewers, MD, PhD, MPH
Source: National Institutes of Health
Amount: $851,192
Term: 1997-2001
Insulin Resistance Atherosclerosis Family Study
Principal Investigator: Marian Rewers, MD, PhD, MPH
Source: National Institutes of Health
Amount: $439,671/yr
Term: 1999-2004
Subclinical Heart Disease in Insulin-Dependent Diabetes
Principal Investigator: Marian Rewers, MD, PhD, MPH
Co-Investigator: Satish Garg, MD
Source: National Institutes of Health
Amount: $671,690/yr
Term: 1999-2004
Immunizations and Type 1 Diabetes
Principal Investigator: Marian Rewers, MD, PhD, MPH
Source: National Institutes of Health, National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK)
Amount: $173,560/yr
Term: 1999-2000
NOD T-Cell Receptors for Specific Islet Autoantigens
Principal Investigator: Eric Simone, MD
Source: National Institutes of Health
Amount: $607,976
Term: 1998-2001
American Diabetes Association Career Development Award
Principal Investigator: Lori Sussel, PhD
Source: American Diabetes Association
Amount: $300,000
Term: 2000-2003
Diabetes Endocrine Research Center Pilot and Feasibility Grant
Principal Investigator: Lori Sussel, PhD
Source: National Institutes of Health
Amount: $50,000
Term: 2000-2001
UCD/Barbara Davis Center Start-up Package
Principal Investigator: Lori Sussel, PhD
Source: University of Colorado Denver
Amount: $380,000
Term: 1998-2001
UCD/ Howard Hughes Institute Start-up Award
Principal Investigator: Lori Sussel, PhD
Source: University of Colorado Denver
Amount: $100,000
Term: 1999-2000
Metformin Insulin Compared to Insulin Monotherapy for Treatment of Adolescents with Type 2 Diabetes
Principal Investigator: Phillipe Walravens, MD
Source: Bristol-Meyers Squibb US Pharmaceuticals
Amount: $70,000
Term: 1997-2001
Efficacy and Safety of Inhaled Insulin
Principal Investigator: Phillipe Walravens, MD
Source: Pfizer Inc.
Amount: $58,400
Term: 1999-2001
Long-Term Safety of Inhaled Insulin - Extension of Therapy
Principal Investigator: Phillipe Walravens, MD
Source: Pfizer, Inc.
Amount: $128,824
Term: 1999-2002
Analysis of Human T-Cell Response to Insulin Peptide B:9-23
Principal Investigator: Dale Wegmann, PhD
Co-Investigator: Peter A. Gottlieb, MD
Source: Neurocrine, Inc.
Amount: $354,920
Term: 1996-2000
|
|
